Women who used hormonal birth control in young adulthood were more likely, decades later, to have larger volumes in brain regions tied to memory, cognition and information processing. That finding comes from researchers at the University of Kansas, who examined the relationship between lifetime reproductive hormone exposure and brain structure in 459 women between the ages of 65 and 80.
What distinguishes the work, according to co-lead author Amber Watts, a professor of psychology at KU who collaborates frequently with scientists at the KU Alzheimer's Disease Research Center, is that it looked at hormone-based medication use at two separate points in life: early adulthood and midlife. Use during both periods was associated with better brain health in the older women studied. Watts described the pattern as a protective effect of estrogen-based hormone therapies.
The mechanism the team points to is cumulative rather than tied to any single exposure. Watts said the evidence suggests it may be the total accumulation of estrogen across a lifetime - beginning with contraceptives in young adulthood and continuing with menopausal hormone therapy later - that accounts for the benefit. To probe that idea, the team examined three different possibilities for how hormone exposure might operate.
For women and clinicians, the practical value here is in framing questions rather than settling them. This is observational work linking past medication use to brain imaging in a specific age group, so it identifies an association worth pursuing rather than establishing that hormone therapy preserves brain tissue. The dual-window approach does give researchers a more detailed map of when hormone exposure might matter most, which is useful for designing the studies that come next.